<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38249633</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2024</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>The COVID-19 Severity and Its Association with Intestinal Parasite Coinfection and Urine Biochemical Parameters among COVID-19-Confirmed Patients Admitted to Debre Markos University COVID-19 Center, Northwest Ethiopia.</ArticleTitle><Pagination><StartPage>3064374</StartPage><MedlinePgn>3064374</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3064374</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2024/3064374</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Though most people with COVID-19 disease show asymptomatic to mild illness, a substantial number of patients are at high risk of developing severe disease and adverse outcomes with long COVID-19 and death. Even though some studies showed that previously existing infections with parasites amend the host's body defenses to increase resistance to infection with SARS-CoV-2, there is limited data in Ethiopia.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study is aimed at determining the COVID-19 disease severity and its association with intestinal parasite coinfection and urine biochemical parameters among COVID-19-confirmed patients admitted at Debre Markos University COVID-19 Center, 2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A prospective cohort study was conducted on 136 RT-qPCR-confirmed COVID-19 patients admitted at Debre Markos University COVID-19 Center from January 1 to March 30, 2021. Sociodemographic and clinical data were collected by using standardized data collection forms. A urine biochemical test was performed using a dry urine dipstick kit and stool examination using direct wet mount microscopic examination and formalin-ether concentration method. The chi-square test, Fisher exact test, and ordinal logistic regression analysis were computed to assess association with outcome variables using Statistical Package for Social Science software (version 24).</AbstractText><AbstractText Label="RESULT" NlmCategory="UNASSIGNED">A total of 136 COVID-19-confirmed patients participated in this study. The median age of the participants was 48 years. The majority (86 (62.5%)) of them were male in sex. Of the 136 cases, 39 (28.7%) had died. Among the 136 patients, 22 (16.2%) were coinfected with intestinal parasites. COVID-19 patients who have intestinal parasite coinfection had lower odds of developing clinically severe COVID-19 compared to noninfected (AOR = 0.37; 95% CI = 0.147-0.944; <i>P</i> = 0.037). The majority (104 (76.5%)) of them have abnormal urine biochemical results. From the abnormal urine biochemical tests observed, the urine blood, glucose, and ketone tests were positive for 54 (39.7%), 36 (26.5%), and 30 (21.1%) patients, respectively. Among the 31 critical COVID-19 patients, 25 (80.6%) showed abnormal urine biochemical parameters. Age and comorbidity were significantly associated with COVID-19 severity (<i>P</i> &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Patients with old age and comorbidity had an increased risk of developing severe COVID-19 disease. Patients having SARS-CoV-2 and intestinal parasitic coinfections demonstrated mild COVID-19 disease severity. Abnormal urine biochemical results were common among critical COVID-19 patients. Thus, advanced study on the effect of the interaction among intestinal parasites on COVID-19 clinical severity and its mechanisms is essential.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Milkiyas Toru et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toru</LastName><ForeName>Milkiyas</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8278-0343</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science, College of Health Science, Debre Markos University, Debre Markos, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atnaf</LastName><ForeName>Aytenew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9512-4369</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science, College of Health Science, Debre Markos University, Debre Markos, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mengist</LastName><ForeName>Hylemariam Mihiretie</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0002-8467-6985</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science, College of Health Science, Debre Markos University, Debre Markos, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reta</LastName><ForeName>Alemayehu</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5086-0776</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science, College of Health Science, Debre Markos University, Debre Markos, Ethiopia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010271" MajorTopicYN="Y">Parasites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005002" MajorTopicYN="N" Type="Geographic">Ethiopia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014495" MajorTopicYN="N">Universities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007411" MajorTopicYN="Y">Intestinal Diseases, Parasitic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>5</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38249633</ArticleId><ArticleId IdType="pmc">PMC10799708</ArticleId><ArticleId IdType="doi">10.1155/2024/3064374</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet . 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D. S., Azhar E. I., Madani T. A., et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global healththe latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases . 2020;91:264&#x2013;266. doi: 10.1016/j.ijid.2020.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.01.009</ArticleId><ArticleId IdType="pmc">PMC7128332</ArticleId><ArticleId IdType="pubmed">31953166</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J. F.-W., Yuan S., Kok K.-H., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet . 2020;395(10223):514&#x2013;523. doi: 10.1016/S0140-6736(20)30154-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30154-9</ArticleId><ArticleId IdType="pmc">PMC7159286</ArticleId><ArticleId IdType="pubmed">31986261</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. 
Transmission of SARS-CoV-2: implications for infection prevention precautions
. WHO; 2020.  August 2020,  https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions.</Citation></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., et al. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine . 2020;382(8):727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W., Zhao X., Ma X., et al. A novel coronavirus genome identified in a cluster of pneumonia cases&#x2014;Wuhan, China 2019&#x2212;2020. China CDC Weekly . 2020;2(4):61&#x2013;62. doi: 10.46234/ccdcw2020.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2020.017</ArticleId><ArticleId IdType="pmc">PMC8393069</ArticleId><ArticleId IdType="pubmed">34594763</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet . 2020;395(10223):507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A., Okorie C., Marinkovic A., et al. Comorbidity and its impact on patients with COVID-19. SN Comprehensive Clinical Medicine . 2020;2(8):1069&#x2013;1076. doi: 10.1007/s42399-020-00363-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00363-4</ArticleId><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Chen S., Liu M., Nie H., Lu H. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging and Disease . 2020;11(3):668&#x2013;678. doi: 10.14336/AD.2020.0502.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0502</ArticleId><ArticleId IdType="pmc">PMC7220287</ArticleId><ArticleId IdType="pubmed">32489711</ArticleId></ArticleIdList></Reference><Reference><Citation>Honardoost M., Janani L., Aghili R., Emami Z., Khamseh M. E. The association between presence of comorbidities and COVID-19 severity: a systematic review and meta-analysis. Cerebrovascular Diseases . 2021;50(2):132&#x2013;140. doi: 10.1159/000513288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513288</ArticleId><ArticleId IdType="pmc">PMC7900456</ArticleId><ArticleId IdType="pubmed">33530081</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukrisman L., Sinto R., Priantono D. Hematologic profiles and correlation between absolute lymphocyte count and neutrophil/lymphocyte ratio with markers of inflammation of COVID-19 in an Indonesian national referral hospital. International Journal of General Medicine . 2021;14:6919&#x2013;6924. doi: 10.2147/IJGM.S337440.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S337440</ArticleId><ArticleId IdType="pmc">PMC8536878</ArticleId><ArticleId IdType="pubmed">34703296</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Sang L., Jiang M., et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. Journal of Allergy and Clinical Immunology . 2020;146(1):89&#x2013;100. doi: 10.1016/j.jaci.2020.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7212968</ArticleId><ArticleId IdType="pubmed">32407836</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger R. E. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. The Journal of Urology . 2005;174(3):941&#x2013;942. doi: 10.1016/S0022-5347(01)68458-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5347(01)68458-1</ArticleId><ArticleId IdType="pubmed">16093998</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdman P., Anderson B., Zacko J. C., Taylor K., Donaldson K. The accuracy of the Sysmex UF-1000i in urine bacterial detection compared with the standard urine analysis and culture. Archives of Pathology &amp; Laboratory Medicine . 2017;141(11):1540&#x2013;1543. doi: 10.5858/arpa.2016-0520-OA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2016-0520-OA</ArticleId><ArticleId IdType="pubmed">28758790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotez P. J., Alvarado M., Bas&#xe1;&#xf1;ez M.-G., et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Neglected Tropical Diseases . 2014;8(7, article e2865) doi: 10.1371/journal.pntd.0002865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002865</ArticleId><ArticleId IdType="pmc">PMC4109880</ArticleId><ArticleId IdType="pubmed">25058013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolday D., Tasew G., Amogne W., et al. Interrogating the impact of intestinal parasite-microbiome on pathogenesis of COVID-19 in sub-Saharan Africa. Frontiers in Microbiology . 2021;12, article 614522 doi: 10.3389/fmicb.2021.614522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.614522</ArticleId><ArticleId IdType="pmc">PMC8086792</ArticleId><ArticleId IdType="pubmed">33935986</ArticleId></ArticleIdList></Reference><Reference><Citation>Herricks J. R., Hotez P. J., Wanga V., et al. The global burden of disease study 2013: what does it mean for the NTDs? PLoS Neglected Tropical Diseases . 2017;11(8, article e0005424) doi: 10.1371/journal.pntd.0005424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005424</ArticleId><ArticleId IdType="pmc">PMC5542388</ArticleId><ArticleId IdType="pubmed">28771480</ArticleId></ArticleIdList></Reference><Reference><Citation>White M. P., McManus C. M., Maizels R. M. Regulatory T-cells in helminth infection: induction, function and therapeutic potential. Immunology . 2020;160(3):248&#x2013;260. doi: 10.1111/imm.13190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13190</ArticleId><ArticleId IdType="pmc">PMC7341546</ArticleId><ArticleId IdType="pubmed">32153025</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradbury R. S., Piedrafita D., Greenhill A., Mahanty S. Will helminth co-infection modulate COVID-19 severity in endemic regions? Nature Reviews Immunology . 2020;20(6):p. 342. doi: 10.1038/s41577-020-0330-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0330-5</ArticleId><ArticleId IdType="pmc">PMC7193760</ArticleId><ArticleId IdType="pubmed">32358579</ArticleId></ArticleIdList></Reference><Reference><Citation>Girma D., Dejene H., Adugna L., Tesema M., Awol M. COVID-19 case fatality rate and factors contributing to mortality in Ethiopia: a systematic review of current evidence. Infection and Drug Resistance . 2022;15:3491&#x2013;3501. doi: 10.2147/IDR.S369266.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S369266</ArticleId><ArticleId IdType="pmc">PMC9270043</ArticleId><ArticleId IdType="pubmed">35813083</ArticleId></ArticleIdList></Reference><Reference><Citation>International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 CRF.  August 2020,  https://isaric.tghn.org/COVID-19-CRF/</Citation></Reference><Reference><Citation>Jin Y.-H., Cai L., Cheng Z.-S., et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Military Medical Research . 2020;7(1):1&#x2013;23. doi: 10.1186/s40779-020-0233-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-020-0233-6</ArticleId><ArticleId IdType="pmc">PMC7003341</ArticleId><ArticleId IdType="pubmed">32029004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A., Zhao W., Xu Z., Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Research and Clinical Practice . 2020;162, article 108118 doi: 10.1016/j.diabres.2020.108118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108118</ArticleId><ArticleId IdType="pmc">PMC7102524</ArticleId><ArticleId IdType="pubmed">32179126</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebrecherkos T., Gessesse Z., Kebede Y., et al. Effect of co-infection with parasites on severity of COVID-19 . medRxiv; 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.02.21250995</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings M. J., Baldwin M. R., Abrams D., et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet . 2020;395(10239):1763&#x2013;1770. doi: 10.1016/S0140-6736(20)31189-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31189-2</ArticleId><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yu Y., Xu J., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine . 2020;8(5):475&#x2013;481. doi: 10.1016/S2213-2600(20)30079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Zangrillo A., Zanella A., et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. Jama . 2020;323(16):1574&#x2013;1581. doi: 10.1001/jama.2020.5394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Zhang Z., Dobrinina M., et al. Urinalysis, but not blood biochemistry, detects the early renal impairment in patients with COVID-19. Diagnostics . 2022;12(3):p. 602. doi: 10.3390/diagnostics12030602.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12030602</ArticleId><ArticleId IdType="pmc">PMC8947192</ArticleId><ArticleId IdType="pubmed">35328155</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Ma Q., Han H., et al. The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019. Clinical Chemistry and Laboratory Medicine . 2020;58(7):1121&#x2013;1124. doi: 10.1515/cclm-2020-0220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0220</ArticleId><ArticleId IdType="pubmed">32286242</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey E. F., McDermott R. A., McDonald M. I. Do worms protect against the metabolic syndrome? A systematic review and meta-analysis. Diabetes Research and Clinical Practice . 2016;120:209&#x2013;220. doi: 10.1016/j.diabres.2016.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2016.08.014</ArticleId><ArticleId IdType="pubmed">27596058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ademe M., Girma F. The influence of helminth immune regulation on COVID-19 clinical outcomes: is it beneficial or detrimental? Infection and Drug Resistance . 2021;14:4421&#x2013;4426. doi: 10.2147/IDR.S335447.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S335447</ArticleId><ArticleId IdType="pmc">PMC8558425</ArticleId><ArticleId IdType="pubmed">34737582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssebambulidde K., Segawa I., Abuga K. M., et al. Parasites and their protection against COVID-19-ecology or immunology? MedRxiv; 2020.</Citation></Reference><Reference><Citation>Mbow M., Lell B., Jochems S. P., et al. COVID-19 in Africa: dampening the storm? Science . 2020;369(6504):624&#x2013;626. doi: 10.1126/science.abd3902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3902</ArticleId><ArticleId IdType="pubmed">32764055</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonte L., Acosta A., Sarmiento M. E., Ginori M., Garc&#xed;a G., Norazmi M. N. COVID-19 lethality in sub-Saharan Africa and helminth immune modulation. Frontiers in Immunology . 2020;11:p. 2459. doi: 10.3389/fimmu.2020.574910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.574910</ArticleId><ArticleId IdType="pmc">PMC7578247</ArticleId><ArticleId IdType="pubmed">33117371</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Wang M., Wang J., Li R., Zhang Y. Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Frontiers in Cellular and Infection Microbiology . 2019;9:p. 206. doi: 10.3389/fcimb.2019.00206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00206</ArticleId><ArticleId IdType="pmc">PMC6581668</ArticleId><ArticleId IdType="pubmed">31245306</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>